BriaCell Therapeutics (BCTX) said Sunday it priced a best-efforts offering of roughly 1.4 million shares at $3.25 each, raising gross proceeds of about $4.7 million.
The offering is expected to close on Tuesday.
The company said it plans to use the proceeds for working capital, general corporate purposes, and advancing its business objectives.